WO2002008390A3 - Bovine wasting syndrome vaccine - Google Patents

Bovine wasting syndrome vaccine Download PDF

Info

Publication number
WO2002008390A3
WO2002008390A3 PCT/EP2001/008297 EP0108297W WO0208390A3 WO 2002008390 A3 WO2002008390 A3 WO 2002008390A3 EP 0108297 W EP0108297 W EP 0108297W WO 0208390 A3 WO0208390 A3 WO 0208390A3
Authority
WO
WIPO (PCT)
Prior art keywords
bovine
wasting syndrome
syndrome vaccine
vaccine
wasting
Prior art date
Application number
PCT/EP2001/008297
Other versions
WO2002008390A2 (en
Inventor
Danny Goovaerts
Der Heijden-Liefkens Karin Van
Jean Guillaume Joseph Demaret
Woensel Petrus Alphonsus M Van
Original Assignee
Akzo Nobel Nv
Danny Goovaerts
Heijden Liefkens Karin V D
Jean Guillaume Joseph Demaret
Woensel Petrus Alphonsus Maria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Danny Goovaerts, Heijden Liefkens Karin V D, Jean Guillaume Joseph Demaret, Woensel Petrus Alphonsus Maria filed Critical Akzo Nobel Nv
Publication of WO2002008390A2 publication Critical patent/WO2002008390A2/en
Publication of WO2002008390A3 publication Critical patent/WO2002008390A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/EP2001/008297 2000-07-21 2001-07-17 Bovine wasting syndrome vaccine WO2002008390A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00202623 2000-07-21
EP00202623.5 2000-07-21

Publications (2)

Publication Number Publication Date
WO2002008390A2 WO2002008390A2 (en) 2002-01-31
WO2002008390A3 true WO2002008390A3 (en) 2002-04-25

Family

ID=8171843

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/008297 WO2002008390A2 (en) 2000-07-21 2001-07-17 Bovine wasting syndrome vaccine

Country Status (1)

Country Link
WO (1) WO2002008390A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663403A1 (en) * 1993-11-23 1995-07-19 Akzo Nobel N.V. Vector vaccines of bovine herpesvirus I
EP0693551A1 (en) * 1994-07-18 1996-01-24 Akzo Nobel N.V. gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission
US5760175A (en) * 1996-09-05 1998-06-02 Bio-Virus Research Incorporated Peptide to detect several herpes virus infections
WO2000023103A1 (en) * 1998-10-16 2000-04-27 Stichting Dienst Landbouwkundig Onderzoek Viral mastitis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0663403A1 (en) * 1993-11-23 1995-07-19 Akzo Nobel N.V. Vector vaccines of bovine herpesvirus I
EP0693551A1 (en) * 1994-07-18 1996-01-24 Akzo Nobel N.V. gD-negative bovine herpesvirus mutant, capable of direct cell-to-cell transmission
US5760175A (en) * 1996-09-05 1998-06-02 Bio-Virus Research Incorporated Peptide to detect several herpes virus infections
WO2000023103A1 (en) * 1998-10-16 2000-04-27 Stichting Dienst Landbouwkundig Onderzoek Viral mastitis

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
BUBLOT M., LOMONTE P., LEQUARRE A.-S., ALBRECHT J.-C., NICHOLAS J., RA FLECKENSTEIN B., PASTORET P.-P., THIRY E.: "Genetic relationships between bovine herpesvirus 4 and the RT gammaherpesviruses Epstein-Barr virus and herpesvirus saimiri", VIROLOGY 190:654-665(1992)., XP001053328 *
DE JONG M.C.M.: "De oorzaken van slijters: wat wel niet geconcludeerd kan worden", TIJDSCHRIFT VOOR DIERGENEESKUNDE, vol. 126, no. 6, 15 March 2001 (2001-03-15), pages 231 - 232, XP008000202 *
LOMONTE P., BUBLOT M., VAN SANTEN V., KEIL G.M., PASTORET P.P., THIRY E.;: "Analysis of bovine herpesvirus 4 genomic regions located outside the conserved gammaherpesvirus gene blocks", J. GEN. VIROL. 76:1835-1841(1995)., XP001053327 *
LOMONTE P., FILEE P., LYAKU J.R., BUBLOT M., PASTORET P.P., THIRY E.; RT: ""Analysis of the biochemical properties of, and complex formation between, RT glycoproteins H and L of the gamma-2 herpesvirus bovine herpesvirus-4";", J. GEN. VIROL. 78:2015-2023(1997)., XP001058998 *
MEIJER G. A. L. ET AL.: "Mogelijkheden voor nader onderzoek naar de slijterproblematiek", TIJDSCHRIFT VOOR DIERGENEESKUNDE, vol. 126, no. 6, 15 March 2001 (2001-03-15), pages 223 - 225, XP008000205 *
OPDENBOSCH VAN E ET AL: "BHV4 (BOVINE HERPES VIRUS 4) RELATED DISORDERS IN BELGIAN CATTLE: A STUDY OF TWO PROBLEM HERDS", VETERINARY RESEARCH COMMUNICATIONS, AMSTERDAM, NL, vol. 12, 1988, pages 347 - 353, XP000876962, ISSN: 0165-7380 *
SCHUKKEN, Y.H.: "Wat weten we nu eigenlijk zeker?", TIJDSCHRIFT VOOR DIERGENEESKUNDE, XP000800020 *
WEBER M.F. & VERHOEFF J.: "Prevalentie van slijtend rundvee op Nederlandse melkveebedrijven met een historie van chronische gezondheidsproblemen", TIJDSCHRIFT VOOR DIERGENEESKUNDE, vol. 126, 15 March 2001 (2001-03-15), pages 180 - 183, XP008000201 *
WENTINK G.H.: "Slijters???", TIJDSCHRIFT VOOR DIERGENEESKUNDE, XP008000200 *
ZIMMERMANN W., BROLL H., EHLERS B., BUHK H.-J., ROSENTHAL A., GOLTZ M.;: ""Genome Sequence of Bovine Herpesvirus 4, a Bovine Rhadinovirus, and RT Identification of an Origin of DNA Replication";", J. VIROL. 75(3):1186-1194(2001)., XP001059418 *

Also Published As

Publication number Publication date
WO2002008390A2 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU4433702A (en) Vaccines
GB0020953D0 (en) Vaccine
HUP0301043A3 (en) Vaccine
IL155072A0 (en) Vaccine
AU8189501A (en) Vaccine composition
HUP0302117A3 (en) Vaccine composition
HUP0402259A3 (en) Vaccines
GB0024200D0 (en) Component vaccine
PT1265633E (en) Adjuvant for vaccines
AU1591402A (en) Vaccine
MA25489A1 (en) VACCINES
GB0014288D0 (en) Vaccine
GB9901254D0 (en) Vaccines
ATE519775T1 (en) RECOMBINANT SUBUNIT VACCINES
GB0026334D0 (en) Vaccine
GB0014845D0 (en) Vaccine
AU2001247453A1 (en) Genetically stable cholera vaccines
WO2002008390A3 (en) Bovine wasting syndrome vaccine
GB0025694D0 (en) Vaccine
GB0105238D0 (en) Vaccines
GB0004533D0 (en) Vaccines
GB0027433D0 (en) Vaccine component
GB0015722D0 (en) Vaccine
GB0006693D0 (en) Vaccine
GB0015935D0 (en) Vaccine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase